Evidence map›Paper›PMID 35869980›Full record

ArticleMedical mycology2022

Ozonated oil is effective at killing Candida species and Streptococcus mutans biofilm-derived cells under aerobic and microaerobic conditions.

Barbara Higa, Bianca Souza Cintra, Carmen Magaly Álvarez, Arthur Barcelos Ribeiro, Jair Camargo Ferreira, Denise Crispim Tavares, Vanessa Enriquez, Luis R Martinez, Regina Helena Pires

Open access · greenAbstract read
In one paragraph

Article in Medical mycology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 3 countries.

Barbara HigaLaboratory of Mycology and Environmental Diagnosis, Universidade de Franca, Franca, São Paulo 14.404-600, Brazil.
Bianca Souza CintraLaboratory of Mycology and Environmental Diagnosis, Universidade de Franca, Franca, São Paulo 14.404-600, Brazil.
Carmen Magaly ÁlvarezLaboratory of Mycology and Environmental Diagnosis, Universidade de Franca, Franca, São Paulo 14.404-600, Brazil.
Arthur Barcelos RibeiroMutagenesis Laboratory, Universidade de Franca, Franca, São Paulo 14.404-600, Brazil.
Jair Camargo FerreiraPostgraduate Program in Animal Science, Universidade de Franca, Franca, São Paulo 14.404-600, Brazil.ORCID 0000-0001-6908-3463
Denise Crispim TavaresMutagenesis Laboratory, Universidade de Franca, Franca, São Paulo 14.404-600, Brazil.ORCID 0000-0003-4646-5914
Vanessa EnriquezDepartment of Oral Biology, College of Dentistry, University of Florida, Gainesville, Florida 32610, USA.
Luis R MartinezDepartment of Oral Biology, College of Dentistry, University of Florida, Gainesville, Florida 32610, USA.ORCID 0000-0001-6372-6501
Regina Helena PiresLaboratory of Mycology and Environmental Diagnosis, Universidade de Franca, Franca, São Paulo 14.404-600, Brazil.ORCID 0000-0002-6004-5951
Universidade de Franca · BRUniversity of Florida · US

Funding

Comprehensive Training Program in Oral BiologyT90DE021990 · NIDCR · UNIVERSITY OF FLORIDA · PI Jose A Lemos · 2011 to 2026
$8.2M
Unraveling Cryptococcus neoformans mechanisms of brain invasion and colonizationR01AI145559 · NIAID · UNIVERSITY OF TEXAS EL PASO · PI MARTINEZ, LUIS R · 2019 to 2023
$2.6M
Comprehensive Training Program in Oral BiologyR90DE022530 · NIDCR · UNIVERSITY OF FLORIDA · PI LEMOS, JOSE A · 2011 to 2025
$995k
Coordenação de Aperfeiçoamento de Pessoal de Nível SuperiorFundação de Amparo à Pesquisa do Estado de São Paulo 2019/26418-8National Institute of Allergy and Infectious Diseases R01AI145559NIAID NIH HHS R01 AI145559NIDCR NIH HHS R90 DE022530NIH HHS T90DE021990
6 · The paper itself

Abstract

This study explores the growth of bacterial, fungal, and interkingdom biofilms under aerobiosis or microaerobic conditions and the effect of ozonated sunflower oil on these biofilms. Candida species and Streptococcus mutans were used to study this interaction due to their importance in oral health and disease as these microorganisms display a synergistic relationship that manifests in the onset of caries and tooth decay. Biofilms were developed in a 96-well microtiter plate at 37ºC for 24 h, under aerobiosis or microaerobic conditions, and treated with ozonated oil for 5 to 120 min. All the microorganisms formed biofilms in both oxygenation conditions. Scanning electron microscopy was used to visualize biofilm morphology. Rodent experiments were performed to verify the oil-related toxicity and its efficacy in oral candidiasis. The growth of all Candida species was increased when co-cultured with S. mutans, whilst the growth of bacterium was greater only when co-cultured with C. krusei and C. orthopsilosis under aerobiosis and microaerobic conditions, respectively. Regardless of the oxygenation condition, ozonated oil significantly reduced the viability of all the tested biofilms and infected mice, showing remarkable microbicidal activity as corroborated with confocal microscopy and minimal toxicity. Thus, ozonated oil therapy can be explored as a strategy to control diseases associated with these biofilms especially in the oral cavity. LAY SUMMARY: We demonstrated that ozonated sunflower oil is effective at killing the biofilms formed by Candida species, by the bacterium Streptococcus mutans, or by both micoorganisms that can interact in the oral cavity, making it a potential therapeutic option for the treatment of these infections.

Indexed as

CandidaStreptococcus mutansAnimalsBiofilmsCandida albicansMiceSunflower OilSunflower OilBiofilmsCandidaoral candidiasisozoneStreptococcus mutanssunflower oil

Identifiers

PMID35869980
PMCPMC9359064
OpenAlexW4286750396

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.